Main Logo
Logo

Society for Pediatric Radiology – Poster Archive

  168
  0
  0
 
 


Final ID: Poster #: CR-006

Rare Case of Severe Ovarian Enlargement in an Infant with Significant Insulin Resistance.

Purpose or Case Report: Massive ovarian enlargement (without underlying mass) is a rare finding in neonates. Ovarian enlargement has been associated with insulin-resistant states such as polycystic ovarian syndrome (PCOS) and rare congenital syndromes such as infants with leprechaunism. However, the extent, severity, and radiographic findings of ovarian growth in infants with syndromes of insulin resistance have not been fully described. We report a case of severe ovarian enlargement in an infant with congenital insulin resistance.

A two-month-old born at 37 weeks via C-section with a history of intrauterine growth restriction was admitted for hyperglycemia consistent with neonatal diabetes and was subsequently diagnosed with insulin resistance syndrome (either leprechaunism or Rabson-Mendenhall syndrome) secondary to an INSR gene mutation. Insulin and proinsulin levels at 3 weeks of age were markedly elevated to 582.3 uIU/mL (2.0 – 19.6) and 674.3 pmol/L (≤ 18.8), respectively.

An abdominal ultrasound (US) performed for abdominal distension demonstrated very enlarged ovaries containing sub-centimeter follicles. Ovarian volumes were 12.8 mL and 8.7 mL on the right and left, respectively. The mean ovarian volume for this age is 1.06 mL with a standard deviation (SD) of 0.96; this would place this patient's right and left ovaries 12.2 and 8.0 SD above the mean, respectively.

CT performed at three months of age for evaluation of persistent fevers demonstrated further enlargement of the ovaries. Ovarian volumes were 106 mL and 60 mL on the right and left, which were 109 and 61 SD above the mean, respectively. A repeat US performed at four months of age showed decreasing ovarian volumes measuring 51 mL and 18 mL on the right and left, respectively (which were still 49 and 25 SD above the mean).

We postulate that this case of massive ovarian enlargement in the setting of severe insulin resistance was likely due to an insulin-mediated gonadotropin-independent mechanism, as has been previously suggested in infants with leprechaunism (perhaps mediated through an intact homologous IGF-I receptor). The ovarian enlargement seen in post-pubertal females with PCOS may have a similar pathogenesis, with resultant granulosa cell proliferation with antral follicles. Ovarian cysts have also been seen in non-insulin-resistant hyperinsulinemic infants of diabetic mothers, suggesting that high circulating serum insulin may act in the trophic manner typical of gonadotropic hormones.
Methods & Materials:
Results:
Conclusions:
  • Mikhchi, Amir  ( Children's Hospital Los Angeles , Los Angeles , California , United States )
  • Ryabets-lienhard, Anna  ( Children's Hospital Los Angeles , Los Angeles , California , United States )
  • Cheung, Clement  ( Children's Hospital Los Angeles , Los Angeles , California , United States )
  • Geffner, Mitchell  ( Children's Hospital Los Angeles , Los Angeles , California , United States )
  • Lai, Lillian  ( Children's Hospital Los Angeles , Los Angeles , California , United States )
Session Info:

Posters - Case Report

Fetal Imaging / Neonatal

SPR Posters - Case Reports

More abstracts on this topic:
Native True-FISP MRA for Assessment of Post-Transplant Renal Artery Stenosis

Infante Juan

Prenatal Diagnosis of Closed Cloacal Exstrophy Variant

Oliver Edward, Gitman Olga, Gebb Juliana, Weiss Dana, Canning Douglas, Hedrick Holly, Howell Lori, Coleman Beverly

More abstracts from these authors:
Pictorial Review of Pitfalls in SPECT-CT I-123 MIBG Imaging of Neuroblastoma

Lai Lillian, Berkovich Rachel, Goodarzian Fariba

Pediatric oncologic emergencies: Must know diagnoses

Sato T Shawn, Lai Lillian, Sato Yutaka

Preview
Poster____CR-006.pdf
You have to be authorized to contact abstract author. Please, Login or Signup.

Please note that this is a separate login, not connected with your credentials used for the SPR main website.

Not Available

Comments

We encourage you to join the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and stimulate conversation and knowledge sharing.

Please click here to review the full terms and conditions for engaging in the discussion, including refraining from product promotion and non-constructive feedback.

 

You have to be authorized to post a comment. Please, Login or Signup.

Please note that this is a separate login, not connected with your credentials used for the SPR main website.


   Rate this abstract  (Maximum characters: 500)